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Abstract
Objective—To determine the impact of surgical site infections (SSIs) on healthcare costs 
following common ambulatory surgical procedures throughout the cost distribution.
Background—Data on costs of SSIs following ambulatory surgery are sparse, particularly 
variation beyond just mean costs.
Methods—We performed a retrospective cohort study of persons undergoing cholecystectomy, 
breast-conserving surgery (BCS), anterior cruciate ligament reconstruction (ACL), and hernia 
repair from 12/31/2004–12/31/2010 using commercial insurer claims data. SSIs within 90 days 
post-procedure were identified; infections during a hospitalization or requiring surgery were 
considered serious. We used quantile regression, controlling for patient, operative, and 
postoperative factors to examine the impact of SSIs on 180-day healthcare costs throughout the 
cost distribution.
Results—The incidence of serious and non-serious SSIs were 0.8% and 0.2% after 21,062 ACL, 
0.5% and 0.3% after 57,750 cholecystectomy, 0.6% and 0.5% after 60,681 hernia, and 0.8% and 
0.8% after 42,489 BCS procedures. Serious SSIs were associated with significantly higher costs 
than non-serious SSIs for all 4 procedures throughout the cost distribution. The attributable cost of 
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serious SSIs increased for both cholecystectomy and hernia repair as the quantile of total costs 
increased ($38,410 for cholecystectomy with serious SSI vs. no SSI at the 70th percentile of costs, 
up to $89,371 at the 90th percentile).
Conclusions—SSIs, particularly serious infections resulting in hospitalization or surgical 
treatment, were associated with significantly increased healthcare costs after 4 common surgical 
procedures. Quantile regression illustrated the differential effect of serious SSIs on healthcare 
costs at the upper end of the cost distribution.
Infections are one of the most common complications after surgical procedures and a 
significant cause of morbidity. Surgical site infections (SSIs) account for over 20% of 
hospital-acquired infections and are the most common reason for unplanned hospital 
readmission after operation.1–3 SSIs can prolong hospital stays by as much as 7 to 11 days, 
and are estimated to result in annual costs of $3.5 billion or more in the US.2 Numerous 
estimates are available for the healthcare costs attributable to SSIs per patient; a recent meta 
analysis reported inpatient hospital costs due to SSIs of $20,875 (2012 US Dollars (USD)). 
However, this cost estimate does not take into account additional healthcare costs due to SSI, 
including costs for physician care, laboratory, radiology, and outpatient antibiotics. In 
addition, the reported summary cost attributable to SSIs does not take into account variation 
in attributable costs depending on the type of surgery. Reported costs of SSIs have ranged 
from a low of $3,173 after cesarean section to $28,790 after coronary artery bypass surgery 
(adjusted to 2012 $US).4–6 In general, the costs of SSIs described in the literature have been 
highest for neurologic, cardiac and orthopedic operations, and lowest for less extensive 
operations such as breast surgery and cesarean section, in which the majority of SSIs are 
superficial rather than deep or organ-space.4,5,7–10
Even fewer data are available on the costs of SSIs following procedures performed in 
ambulatory settings, either in free-standing facilities or hospital-affiliated outpatient centers. 
Ambulatory surgery accounts for a growing proportion of surgical procedures, although the 
proportion performed as outpatient surgery varies by surgical specialty.11,12 In a recent 
study, Hollingsworth and colleagues found that the likelihood to perform operations in 
outpatient surgery was higher for orthopedic, urologic, and gastroenterology compared to 
other surgical specialties, and the proportion of these procedures performed as outpatients 
increased over time.12
Rhee et al. reported comprehensive surveillance for SSIs after ambulatory surgery using 
medical claims data and validation with medical record review. They found rates of SSIs 
ranging from 0.5% for cholecystectomy, 0.7% after anterior cruciate ligament reconstruction 
(ACL), 1.3% for hernia repair, to 3.2% after appendectomy.13 Deep SSI rates after a variety 
of orthopedic surgeries performed by the same surgeons ranged from 0.4–0.8% depending 
on whether operations were performed in a multispecialty ambulatory surgery center (ASC) 
or a dedicated orthopedic ASC.14 In two studies of ambulatory surgeries, 0.6% of lumbar 
discectomies15 and 0.2% of thyroidectomies16 were followed by SSIs identified during a 
hospital readmission within 30 days after operation.
While some information is available concerning the incidence of SSIs after ambulatory 
surgical procedures, data concerning the costs of SSI are sparse. Using a comprehensive 
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nationwide database across a continuum of care, we determined costs associated with SSIs 
and variation in attributable costs across the distribution of total medical costs for four 
common surgical procedures that can be performed in either inpatient or outpatient settings: 
cholecystectomy, breast-conserving surgery (BCS), ACL, and hernia repair.
METHODS
We conducted a retrospective cohort study using the HealthCore Integrated Research 
DatabaseSM, with longitudinal claims data from 13 Anthem-owned Blue Cross and/or Blue 
Shield health plans located in the Southeast, Mid-Atlantic, Eastern, Central, and Western US 
regions. Data included all fully adjudicated claims submitted for reimbursement from 
providers, facilities, and outpatient pharmacies linked to health plan enrollment information.
Fully insured members enrolled in a fee-for-service health plan including medical coverage 
of hospital and physician services and prescription drug coverage were eligible for inclusion 
into the cohort. To assess comorbid conditions and capture costs, we required members to 
have insurance coverage from 365 days before surgery through 180 days after surgery. To 
avoid censoring, we excluded patients who died within 180 days of surgery. Medical claims 
were restricted to paid claims.
Patient populations
We identified cholecystectomy, BCS, ACL, and hernia repair procedures performed from 
12/31/2004–12/31/2010 in members eligible for cohort entry using International 
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and Current 
Procedural Terminology, 4th edition (CPT-4) procedure codes from inpatient and ambulatory 
facilities (other than home health agencies) and provider claims (Supplemental Digital 
Content 1). We included members aged 18 to 64 years for BCS and cholecystectomy and 
members aged 6 months to 64 years for ACL and hernia repair.
Patients were excluded for any of the following reasons, as defined previously17–19: no other 
supporting evidence for the surgery (e.g., surgery coded by provider- or facility-only and no 
CPT-4 codes for anesthesia, pathology, surgery revenue codes); additional procedures 
performed at the same time as the eligible surgery; medically complicated patient; ICD-9-
CM diagnosis code or prescription claim indicating HIV-positive status; history of organ 
transplant in the previous year (ICD-9-CM V42.0–V42.1, V42.6–V42.7, V42.81–V42.84); 
preexisting SSI within 30 days before the surgical procedure; and cholecystectomy or hernia 
repair with discordant provider and facility coding for approach (laparoscopic vs. open) or 
anatomic site. We restricted analyses to the first surgical procedure per patient, per 
procedure type.
Identification of SSIs
SSIs first recorded 2 to 90 days after surgical procedures were identified using ICD-9-CM 
diagnosis codes from inpatient and outpatient facilities and provider claims (Supplemental 
Digital Content 2–4). We excluded claims with locations inconsistent with a provider 
diagnosis (e.g., laboratory, patient’s home) as well as claims with CPT-4 codes for 
laboratory services (88104–88399), since the diagnosis codes on those lines may have been 
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used for “rule-out” diagnoses.17–19 We censored the observation period to avoid 
misclassification of SSIs after a subsequent surgery using the National Healthcare Safety 
Network procedure list.20
We defined serious SSI as infection coded during an inpatient hospitalization (index 
hospitalization or readmission) or requiring surgical treatment within 90 days of the index 
procedure. Surgical treatment included all ICD-9-CM and CPT-4 procedure codes in 
Supplemental Digital Content 2–4 (except ICD-9-CM procedure 85.91, 86.01, and 86.28 for 
BCS), and laparotomy codes for hernia repair and cholecystectomy (ICD-9-CM procedure 
54.11, 54.12, 54.19; CPT-4 49000, 49002). All other SSIs were categorized as non-serious.
Outcomes and covariates
The primary outcome was total medical costs, defined as the total allowed amount for all 
medical and pharmacy claims (i.e., sum of patient- and plan-paid amounts) from the surgery 
date through 180 days after surgery. For statistical analyses, all costs were inflation-adjusted 
to 2014 USD using the medical care component of the Consumer Price Index.21 Natural log 
transformed total costs were used as the dependent variable for all models.
We selected a set of potential confounders that might influence the relationship between 
health care costs and SSI, including patient demographics, comorbid conditions, 
medications, type of facility, operative factors, and postoperative factors (Table 1). We 
utilized the American Hospital Association Annual Survey of Hospitals (Health Forum, 
LLC, Chicago, IL) and the Outpatient Surgery Center Profiling Solution data (IMS Health, 
Plymouth Meeting, PA) to determine whether the surgical procedure was performed at a 
hospital or freestanding ASC. The facility information from these two data sources was 
matched to the operative facility using National Provider Identifier codes, where available; 
otherwise matching was performed using facility name and address fields. Among facilities 
matching to an American Hospital Association hospital, we used an inpatient designation in 
the claims data to define whether the procedure was performed as an inpatient or outpatient.
Statistical analysis
An ordinary least squares (OLS) model was used to identify covariates for inclusion in a 
quantile regression model of total medical costs, with serious and non-serious SSI as the 
primary exposures. Backwards stepwise variable selection was used with cutoff values of 
p<0.10 for entry and p<0.15 for retention. Model fit diagnostics and collinearity were 
assessed.
Quantile regression was used to estimate the conditional percentiles of total cost and 
association with SSI, including the significant covariates identified in the OLS model. The 
quantile regression technique was chosen for the analyses because it enables assessment of 
the effects of a covariate on all parts of the cost distribution (i.e., upper, lower, and median) 
rather than only the mean, as with OLS.22,23 The 95% confidence intervals were 
approximated by bootstrapping with 500 repetitions. Quantile regression for costs was 
performed at intervals of 10% for percentiles from 10% up to 90%, and for the 25% and 
75% percentiles. Interquantile regression analysis was performed for three interquantile 
ranges: 10th to 90th, 10th to 50th, and 50th to 90th quantile. Attributable costs of non-serious 
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and serious SSIs were determined by using total costs rather than the natural log of total 
costs as the dependent variable in the quantile regression models. All data management and 
analyses were performed in SAS version 9.3 (Cary, NC) and Stata version 13 (College 
Station, TX).
RESULTS
Among the eligible patients included in analyses, 21,062 had an ACL, 57,750 had a 
cholecystectomy; 60,681 had a hernia repair procedure; and 42,489 had BCS (Table 2). 
Among ACLs, 40.9% of patients were female with a median age of 30 years. Females made 
up 74.6% of patients in the cholecystectomy cohort (median age 45 years), and 20.1% in the 
hernia repair cohort (median age 48 years). The median age of women in the BCS cohort 
was 49 years. Thirty-three percent of patients in the ACL cohort had surgery performed in 
an ASC. In contrast, the majority of cholecystectomy, hernia repair, and BCS procedures 
were performed as outpatient surgeries in a hospital. One-quarter of cholecystectomy 
procedures were performed during an inpatient hospitalization (Table 2). The procedures 
with missing facility information varied significantly with regard to demographics and 
operative factors compared to facilities with known facility association (data not shown), 
consistent with missing facilities comprising a mixture of free-standing ASC, outpatient 
surgery, and inpatient hospitals.
The incidence of serious and non-serious SSIs by procedure type is shown in Table 2. The 
overall incidence of SSI varied from 0.7% after cholecystectomy to 1.6% after BCS, and the 
proportion classified as serious ranged from 50% after BCS to 80% after ACL. Fifty-six 
percent of SSIs after ACL resulted in reoperation during an inpatient hospitalization, 
compared to 10.7% of the serious SSIs after BCS. Approximately 20% of serious SSIs after 
both cholecystectomy and hernia repair resulted in reoperation during an inpatient 
hospitalization. An additional 59.4% of serious SSIs after cholecystectomy and 48.2% of 
serious SSIs after hernia repair were categorized as “serious” because of medical treatment 
(other than reoperation) during an inpatient hospitalization (Table 2). Histograms of the 
unadjusted total medical costs for the 4 procedures are shown in Figure 1, stratified by SSI. 
The cost distribution shifted to the right in patients with non-serious SSI and serious SSI 
within 90 days of surgery, compared to patients without SSI.
In quantile regression models at the 50th percentile, SSI was associated with higher median 
costs after controlling for underlying health conditions, age, gender, operative variables, and 
facility type, although the magnitude varied depending on the seriousness of the SSI and by 
procedure (Table 3). Serious SSIs were associated with significantly higher costs compared 
with non-serious SSIs; the parameter estimate for serious SSI was almost 5-fold higher than 
for non-serious SSI for cholecystectomy, 3-fold higher for ACL and hernia repair (all p < 
0.001), and 2-fold higher for BCS (p=0.005). Compared with outpatient hospital facilities, 
inpatient hospital procedures were associated with higher costs for all four procedures. Free-
standing ASCs were associated with significantly lower costs compared with outpatient 
hospital facilities for all four procedures, with the greatest impact observed for hernia repair 
(Table 3). Other factors associated with significantly higher median costs included a number 
of underlying conditions (e.g., peripheral vascular disease, diabetes, psychoses, depression, 
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malnutrition or previous weight loss, treatment with disease-modifying antirheumatic drugs 
or biologic agents). Factors significantly associated with costs that were unique to individual 
surgical procedures included choledocholithiasis, and surgical approach stratified by acute 
cholecystitis for cholecystectomy, anatomic site of hernia and laparoscopic approach for 
hernia repair, and highest cancer stage, concurrent lymph node removal, and number of re-
excisions for BCS.
The attributable median costs of infection were significantly higher for serious versus non-
serious SSIs after all surgical procedures: 5-fold higher for ACL ($19,356 versus $3,735), 
10-fold higher for cholecystectomy ($21,451 versus $2,219), 5-fold higher for hernia repair 
($16,489 versus $3,028), and 3-fold higher for serious versus non-serious SSI after BCS 
($6,959 versus $2,425) (Table 4). The attributable costs of both non-serious and serious SSIs 
increased from the 10th to the 90th percentile of total costs (Table 4). The graphs displayed in 
Figure 2 plot the attributable costs for non-serious and serious SSIs across the percentile 
distribution of total costs for the four surgical procedures, controlling for all covariates. The 
attributable costs for both non-serious and serious SSIs after ACL reconstruction increased 
6-fold from the 10th to the 90th percentiles of the cost distribution (Figure 2 and Table 4). A 
6-fold increase in attributable costs for non-serious SSIs from the 10th to the 90th percentile 
was seen in the BCS cohort, with a 5-fold increase in attributable costs of serious SSIs. The 
attributable costs after cholecystectomy increased 4-fold for non-serious SSIs and 15-fold 
for serious SSIs, while the attributable costs of non-serious SSIs increased 7-fold and 11-
fold for serious SSIs after hernia repair from the 10th to the 90th percentiles. Overall, the 
attributable costs of both non-serious and serious SSIs were lower after BCS than for the 
other three surgery types.
Interquantile regression was used to quantify the cost differences of non-serious and serious 
SSIs at different points of the cost distribution (Table 5). For BCS and ACL, the parameter 
estimates for non-serious and serious SSIs were not significant in any of the three 
interquantile models, indicating that costs attributable to serious vs. non-serious SSIs did not 
vary significantly between the tested quantiles. For cholecystectomy and hernia repair, the 
parameter estimates for non-serious SSIs were not significant in any of the three 
interquantile models; however, the parameter estimates for serious SSIs were significant in 
all models, indicating significantly increased attributable costs of serious SSIs between the 
tested quantiles. Correspondingly, the proportion of serious SSIs resulting in reoperation 
during an inpatient hospitalization were highest in the highest decile for both 
cholecystectomy and hernia repair (27%), and the proportion diagnosed and treated during 
an inpatient hospitalization (without reoperation) were higher for both procedures beginning 
with the 80th percentile and above (59–69% for cholecystectomy, 34–58% for hernia repair) 
compared to lower deciles in the cost distribution.
DISCUSSION
In this observational study of persons undergoing four common ambulatory surgical 
procedures SSIs were associated with significantly increased total healthcare costs. Serious 
SSIs were associated with greater costs than non-serious SSIs for all four procedures, which, 
to our knowledge, has not been previously reported. Additionally, we found differences in 
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costs of SSIs across the distribution of total costs by use of quantile regression, which is not 
generally accounted for in studies of costs due to infection.
Most prior studies of costs of SSIs reported single cost estimates without discriminating 
between serious and non-serious SSIs. Recently Schweizer and colleagues reported 
attributable costs of approximately $7,000 for superficial vs. $25,700 for deep SSIs, but 
these estimates were calculated for a mixed group of surgical procedures.10 We found 
significant differences in costs for non-serious and serious SSIs within quantiles for all four 
procedure types, including median attributable costs. This is especially important because 
the proportion of SSIs that required hospitalization or surgical treatment (which we termed 
“serious”) varied by procedure from 50% after BCS compared with 80% after ACL.
The difference we found in attributable costs between serious vs. non-serious SSIs was 
smallest for BCS. The vast majority of SSIs after BCS are superficial, involving only skin 
and soft tissue.24 This is consistent with our finding that the proportion of “serious” 
infections resulting in reoperation during an inpatient hospitalization after BCS was very 
small (10.7%), while almost 50% of the “serious” SSIs were categorized as such based on a 
wound care procedure performed outside of the operating room (i.e., in a clinic or at the 
bedside). In contrast, as we reported previously the majority of SSIs after ACL were coded 
for septic arthritis,18 which would be expected to result in high costs due to the need for 
prolonged intravenous antibiotics and surgical treatment, often leading to removal of 
ligament allografts and subsequent revision surgery. In our cohort, 56% of the serious SSIs 
after ACL required surgical treatment in the operating room during an inpatient 
hospitalization. Serious SSIs after hernia repair and cholecystectomy were likely associated 
with higher costs because of the need for inpatient hospitalization in the majority and 
abdominal surgery in about 20% of cases, presumably to drain abdominal abscesses and 
debride devitalized tissue.
For all of the surgical procedures we studied, there was no significant variation in costs of 
non-serious SSIs across the distribution of total costs, although non-serious SSIs still 
resulted in significantly increased costs compared to uninfected individuals. Treatment of 
non-serious infections would likely have involved only outpatient office visits and oral 
antibiotics (since inpatient hospitalization was incorporated in our definition of serious SSI). 
For both hernia repair and cholecystectomy, the costs of serious SSIs increased significantly 
at the higher end of the cost distribution. For both of these procedures, the proportion of 
serious SSIs diagnosed and treated during an inpatient hospitalization were much higher at 
the upper (80% and above) than at the lower end of the cost distribution, and the proportion 
of serious SSIs resulting in reoperation were highest in the two highest deciles. Thus the 
higher costs of serious SSIs at the upper end of the cost distribution are consistent with 
increased costs due to additional surgery and hospital length of stay.
Our study has a number of strengths and unique features. We used quantile regression to 
assess the difference in economic impact of serious and non-serious SSIs across the 
distribution of overall healthcare costs. Standard analyses often utilize OLS models which 
only assess mean costs and assume that costs are normally distributed, and that infections 
impact costs similarly across the cost distribution. Our findings show that models based on 
Olsen et al. Page 7













differences in mean costs may be insufficient to describe costs due to SSIs and that costs 
vary depending on the severity of infection. Quantile regression is an infrequently used 
econometric technique that may have broader applicability in studies of healthcare 
costs.22,25–28 We used a rich data source that contained information across the spectrum of 
care from inpatient hospitalizations to outpatient clinic visits and prescriptions. We were 
able to include all documented infections regardless of site of care rather than only the 
subset of infections identified at re-admission to the hospital where the index procedure was 
performed. We also included procedures performed at freestanding ASCs and outpatient 
surgeries at a hospital. This is very important given the increasing utilization of outpatient 
surgery for all four of the surgical procedures analyzed.
Our study had several limitations. Coding errors may have resulted in misclassification of 
other complications as infection. In addition, the sensitivity of ICD-9-CM diagnosis codes to 
identify SSIs is imperfect, particularly for minor outpatient infections during the 90-day 
global period for physician reimbursement. The effect of this misclassification would have 
resulted in under-detection of minor SSIs, and thus our estimates for the attributable costs of 
non-serious SSIs may overestimate the true costs. The reduced sensitivity to identify non-
serious SSIs should not have had significant impact on the calculation of costs attributable to 
serious infections, since serious SSIs treated in the outpatient setting would be more likely to 
be coded due to reimbursement of wound care procedures (even in the global reimbursement 
period), and the sensitivity and positive predictive values of the ICD-9-CM diagnosis codes 
we used to identify SSIs diagnosed and treated during inpatient hospitalizations are 
relatively high.29–31 We adjusted for many factors related to both SSI and medical costs in 
the quantile regression models, but there may still be residual confounding due to omitted 
variables (i.e., endogeneity). Although the claims database is large and geographically 
dispersed all patients have private insurance and our findings may not be generalizable to 
patients with other types of insurance in the US or in other countries.
SSIs, especially serious infections resulting in hospitalization or surgical treatment, were 
associated with significantly increased healthcare costs after 4 common surgical procedures. 
Quantile regression illustrated the impact of serious SSIs on healthcare costs across the 
distribution of costs, especially at the upper end of the cost distribution. This study 
demonstrates the additional information on healthcare costs that can be obtained by quantile 
regression modeling, and support use of this method to quantify attributable costs of 
hospital-acquired infections.
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Distribution of total costs stratified by no infection, non-serious surgical site infection (SSI), 
and serious SSI. A) Anterior Cruciate Ligament (ACL) Reconstruction B) Cholecystectomy 
C) Hernia Repair D) Breast-Conserving Surgery (BCS). The X-axis was truncated at 
$200,000. The percentages of patients with total costs greater than $200,000 for the four 
procedures were: 0.01% for ACL reconstruction (maximum $266,995), 0.11% for 
cholecystectomy (maximum $2,199,560), 0.08% for hernia repair (maximum $2,125,635), 
and 0.24% for BCS (maximum $574,680).
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Attributable costs of non-serious and serious surgical site infection (SSI) from the quantile 
regression models across the distribution of total costs. Black lines indicate serious SSI, gray 
lines indicate non-serious SSI; dashed lines indicate 95% confidence intervals. A) Anterior 
Cruciate Ligament Reconstruction B) Cholecystectomy C) Hernia Repair D) Breast-
Conserving Surgery.
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